The post Sui’s 1.72 bugs caused three outages before foundation rolled out major fix appeared on BitcoinEthereumNews.com. Sui said it has completed a major upgradeThe post Sui’s 1.72 bugs caused three outages before foundation rolled out major fix appeared on BitcoinEthereumNews.com. Sui said it has completed a major upgrade

Sui’s 1.72 bugs caused three outages before foundation rolled out major fix

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Sui said it has completed a major upgrade after three outages stopped its mainnet across two days, with the foundation saying known bugs have now been fixed.

Summary

  • Sui said 1.72 release bugs caused two outages, while an interim fix triggered another halt.
  • Validators applied a major upgrade and said known gas-charging and randomness-state bugs were fully addressed.
  • The SUI token fell near 89 cents as repeated network halts drew fresh reliability questions.

The Sui Foundation said the outages happened on May 28 and May 29. The first started at about 7 a.m. PT on Thursday and ended at about 1:30 p.m. PT. The second ran from about 5 a.m. PT to 8:30 a.m. PT on Friday.

A third outage began at about 1:30 p.m. PT on Friday and ended at about 7:20 p.m. PT. “During the outages, no user funds were at risk,” Sui said, adding that the network did not reverse committed transactions after service resumed.

1.72 bugs and interim fix caused halts

Sui linked the first two outages to crash bugs tied to its 1.72 software release. The release introduced address balances, a feature that lets users store funds and pay gas without using coin objects.

The bug affected gas charging when some transactions failed because of low balances. Sui said the system could charge funds before canceling a transaction, creating negative balances that caused validators to crash.

The foundation said an interim fix helped bring the network back while the core team worked on a stronger solution. That temporary fix had a known low-probability issue that later caused another halt on Friday morning.

The third outage came at the next scheduled epoch change. Sui said a separate latent bug affected how validators preserved randomness state across restarts after they adopted the Friday morning fix.

Related coverage adds market context

As previously reported by crypto.news, Sui also suffered a six-hour outage on Jan. 14, 2026, after validators hit a consensus divergence bug. That earlier report said user funds stayed safe during the halt.

Separately, Sui had faced a major disruption in November 2024, when validators became stuck in a crash loop. In April, crypto.news reported that CME planned AVAX and SUI futures, adding regulated market access for institutions.

SUI price remains under pressure

SUI traded near $0.88 after the outages, based on market data. The token had traded near $0.99 before the first outage, leaving it lower after the network problems.

Sui continues to maintain an active DeFi ecosystem. According to DefiLlama, the network has hundreds of millions of dollars in total value locked. Following the outages, Sui said validators have addressed the known gas-charging and randomness-state bugs, and network activity has resumed.

The foundation also named better failure containment, stronger end-of-epoch handling, and more AI-assisted diagnostics as areas for future work.

Source: https://crypto.news/suis-1-72-bugs-caused-three-outages-before-foundation-rolled-out-major-fix/

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.05267
$0.05267$0.05267
-2.15%
USD
Major (MAJOR) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage